One Year Into Pandemic, Biden Promises Vaccines for All U.S. Adults by May 1
Remarks came on the one-year anniversary of the WHO declaring COVID-19 to be a pandemic
Teplizumab Could Delay Diagnosis of Type 1 Diabetes
Teplizumab improves beta-cell function in high-risk individuals with relatives who have type 1 diabetes
Guidelines Provided for Unilateral Lymphadenopathy After COVID-19 Vaccination
In most clinical settings, ipsilateral UAL after recent COVID-19 vaccination is benign finding; clinical follow-up recommended
Prevalence of Vascular Risk Factors High for Hispanics/Latinos
Despite high awareness, secondary stroke prevention strategies are low
In Under 25s, Racial, Ethnic Disparities in COVID-19 Incidence Varied
Largest persistent disparities seen for NH/PI, AI/AN, and Hispanic or Latino persons from January to December 2020
Decline in Kidney Function Faster After COVID-19-Related AKI
Among patients who have in-hospital acute kidney injury, those with AKI tied to COVID-19 have faster rate of decrease in eGFR after discharge
Physical Activity May Improve Cardiorenal Outcomes in CKD
High physical activity level (7.5 to <15 MET hours/week) linked to lower risks for all-cause mortality, ESRD, MACE
Tocilizumab Use Not Supported for Moderate-to-Severe COVID-19
Progression of COVID-19 up to day 14 did not differ with addition of tocilizumab to standard care in Phase 3 trial conducted in India
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
Biden Announces Plan to Buy 100 Million More Doses of J&J Vaccine
President has said that every American adult will have access to a vaccine by the end of May
